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MicroRNA Modulate Alveolar Epithelial Response to Cyclic Stretch
Abstract
Background
MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression implicated in multiple cellular
processes. Cyclic stretch of alveoli is characteristic of mechanical ventilation, and is postulated to be partly
responsible for the lung injury and inflammation in ventilator-induced lung injury. We propose that miRNAs
may regulate some of the stretch response, and therefore hypothesized that miRNAs would be differentially
expressed between cyclically stretched and unstretched rat alveolar epithelial cells (RAECs).
Results
RAECs were isolated and cultured to express type I epithelial characteristics. They were then equibiaxially
stretched to 25% change in surface area at 15 cycles/minute for 1 hour or 6 hours, or served as unstretched
controls, and miRNAs were extracted. Expression profiling of the miRNAs with at least 1.5-fold change over
controls revealed 42 miRNAs were regulated (34 up and 8 down) with stretch. We validated 6 of the miRNAs
using real-time PCR. Using a parallel mRNA array under identical conditions and publicly available databases,
target genes for these 42 differentially regulated miRNAs were identified. Many of these genes had significant
up- or down-regulation under the same stretch conditions. There were 362 down-regulated genes associated
with up-regulated miRNAs, and 101 up-regulated genes associated with down-regulated miRNAs. Specific
inhibition of two selected miRNAs demonstrated a reduction of the increased epithelial permeability seen
with cyclic stretch.
Conclusions
We conclude that miRNA expression is differentially expressed between cyclically stretched and unstretched
alveolar epithelial cells, and may offer opportunities for therapeutic intervention to ameliorate stretch-
associated alveolar epithelial cell dysfunction.
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MicroRNA modulate alveolar epithelial response
to cyclic stretch
Nadir Yehya1,2, Adi Yerrapureddy1, John Tobias3 and Susan S Margulies1*
Abstract
Background: MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression implicated in multiple
cellular processes. Cyclic stretch of alveoli is characteristic of mechanical ventilation, and is postulated to be partly
responsible for the lung injury and inflammation in ventilator-induced lung injury. We propose that miRNAs may
regulate some of the stretch response, and therefore hypothesized that miRNAs would be differentially expressed
between cyclically stretched and unstretched rat alveolar epithelial cells (RAECs).
Results: RAECs were isolated and cultured to express type I epithelial characteristics. They were then equibiaxially
stretched to 25% change in surface area at 15 cycles/minute for 1 hour or 6 hours, or served as unstretched
controls, and miRNAs were extracted. Expression profiling of the miRNAs with at least 1.5-fold change over controls
revealed 42 miRNAs were regulated (34 up and 8 down) with stretch. We validated 6 of the miRNAs using real-time
PCR. Using a parallel mRNA array under identical conditions and publicly available databases, target genes for these
42 differentially regulated miRNAs were identified. Many of these genes had significant up- or down-regulation
under the same stretch conditions. There were 362 down-regulated genes associated with up-regulated miRNAs,
and 101 up-regulated genes associated with down-regulated miRNAs. Specific inhibition of two selected miRNAs
demonstrated a reduction of the increased epithelial permeability seen with cyclic stretch.
Conclusions: We conclude that miRNA expression is differentially expressed between cyclically stretched and
unstretched alveolar epithelial cells, and may offer opportunities for therapeutic intervention to ameliorate stretch-
associated alveolar epithelial cell dysfunction.
Background
Mechanical ventilation of patients with respiratory failure
is known to increase alveolar epithelial permeability [1-3]
and initiate an inflammatory response [4,5], which contri-
butes to the elevated morbidity and mortality seen in these
patients [6-8]. Lower tidal volume ventilation may improve
survival as compared with higher tidal volume ventilation
[9], suggesting that smaller cyclic stretches with less alveo-
lar cell deformation may mitigate some of the damage of
ventilator-induced lung injury (VILI).
The mechanisms behind the increased permeability re-
main unclear. Previous studies have shown decreased
protein content at tight junctions of cyclically stretched
epithelia [10], disorganization of actin monofilaments
[10,11], and elevated intracellular calcium concentrations
[12]. Genomic analysis of tissue homogenates from
whole animals [13-16] and intact mouse lungs [17]
exposed to large tidal volume ventilation consolidate the
responses of multiple cell types, including endothelial,
epithelial, and inflammatory leukocytes. Our group has
recently reported on the genomic response of type I epi-
thelia, which comprise >95% of the surface area of the
alveolus. Cultured primary alveolar epithelial cells with
type I characteristics were exposed to low and moderate
stretch magnitudes (change in surface area, ΔSA, of 12%
or 25%), and varying durations of cyclic stretch (1 hour
or 6 hours) relative to unstretched cells [18]. Both mag-
nitude- and duration-dependent gene expression changes
were evident, implicating several genes previously un-
known to be affected by either in vitro stretch or VILI.
MicroRNAs (miRNAs) are a class of small noncoding
RNAs implicated in multiple physiologic processes via
negative post-transcriptional regulation of messenger
RNAs (mRNAs). The transcription of miRNAs is under
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similar control as that of mRNAs, and their expression
can be similarly profiled [19]. MiRNAs have been impli-
cated in the proliferation and differentiation of myocytes
in response to cyclic stretch [20], suggesting a possible
role for stretch in other cell types. MiRNAs are involved
in the hypoxic response of many cell types [21-24] and
the post-infarct myocardium [25-27], and also in the fi-
brotic response after ischemia/reperfusion [28,29], con-
sistent with their role as modifiers of tissue injury and
healing. Because miRNAs modulate responses, they may
offer potential as therapeutic interventions. Several fea-
tures of miRNAs make them attractive as therapies: miR-
NAs can be efficiently stabilized or inhibited [30,31];
and, some miRNAs regulate multiple mRNAs, and can
therefore potentially modify entire gene networks [30].
Previously, our group developed an in vitro monolayer
with alveolar type I characteristics that mimic lung infla-
tion when subjected to equibiaxial stretch [7,8,10,32].
Using this model, we identified the genome-wide
miRNA expression profile of these cells when subjected
to different durations (1 hour or 6 hours) of cyclic
stretch at a magnitude of 25% ΔSA. Using publicly avail-
able predictive databases [33], we identified likely mRNA
targets of these miRNAs, and further refined our list by
concentrating on mRNAs previously demonstrated to be
differentially expressed in this same cyclically-stretched
monolayer model [18]. Finally, we demonstrated that spe-
cific inhibition of two select miRNAs up-regulated with
stretch partially ameliorates the phenotype of increased
epithelial permeability seen with cyclic stretch, suggesting
a functional role for these miRNAs in regulating the cell
response to stretch.
Methods
Primary Rat Alveolar Epithelial Cell (RAEC) isolation
In a protocol approved by the Animal Care and Use
Committee of the University of Pennsylvania, alveolar
type II cells were isolated from male Sprague–Dawley
rats based on a method reported by Dobbs et al. [34],
with the slight modification reported earlier [35]. Type II
cells were seeded onto fibronectin-coated (10 μg/cm2)
flexible silastic membranes (Specialty Manufacturing,
Saginaw, MI), mounted in custom-designed wells at a
density of 106 cells/cm2. The cells were cultured for
5 days with MEM supplemented with 10% fetal bovine
serum, until they attained alveolar type I cell characteris-
tics [32]. Then these RAEC were serum-deprived with
20 mM Hepes supplemented with DMEM (CO2-free
buffering system) for 2 hours, subjected to biaxial cyclic
stretch (25% ΔSA) at 37°C for one of two durations (1
hour or 6 hours) at a frequency of 0.25 Hz (15 cycles/
min). The two stretch groups were designated 25*1 and
25*6. All the samples were compared to unstretched
control wells.
Total RNA isolation
Total RNA was extracted from the cells (Qiagen miRN
easy mini kit cat# 217004, Qiagen Inc, Valencia, CA)
according to the manufacturer’s instructions. RNA samples
were obtained from every experimental group. The quan-
tity and quality of the RNA samples were measured (Agi-
lent Bioanalyzer and Nanodrop spectrophotometer).
Samples with low RNA integrity number were discarded.
The final group used in the microarray analysis included
12 samples, with N = 4 animals/group. The miRNA micro-
array protocols were conducted as described in the Exiqon
LNA microRNA Amplification protocol at University of
Pennsylvania Microarray Core Facility, and the raw miRNA
expression data were evaluated.
MiRNA microarray data analysis
The miRNA expression data were imported into Partek
Genomics Suite (v6.4, Partek Inc., St. Louis, MO). The
probes were filtered for chip-to-chip differences with
Loess non-linear normalization [36], and only those
probes with a significant detection (p< 0.05) in at least 3
of the 12 samples were retained, leaving 1279 for subse-
quent analysis. The intensity values of the remaining
probes were transformed (log2). Pairwise contrasts be-
tween the control and each of the two stretch groups
(25*1 and 25*6) were also determined in a post-hoc ana-
lysis. No significant array or animal effect was observed
in the data. The complete miRNA expression microarray
data set is available via Gene Expression Omnibus acces-
sion number GSE36256.
To attribute significance to any of the p-values calcu-
lated in the ANOVA and pairwise contrasts, we used a
10% False Discovery Rate (FDR, Benjamini-Hochberg,
step-up) cutoff for analysis of the data [37]. Based on this
criterion, there were a total of 52 miRNAs with at least
one significant p-value in the two pairwise comparisons.
This miRNA set was further filtered to investigate only
those miRNAs with expressions that were altered at least
1.5-fold up or down in at least one of the comparisons
with controls, leaving 42 miRNAs for subsequent analyses.
Target prediction
To identify the possible gene targets that are regulated
by these 42 miRNAs, we used two publicly available tar-
get prediction databases: TargetScan 5.1 [38] and Micro-
Cosm Targets 5.0. We limited our analysis to those gene
targets predicted by both databases. TargetScan assigns a
context score and context percentile to each predicted
gene target for a particular miRNA, and we used a Tar-
getScan cutoff of ≥50th context percentile. We defined
any of our 42 miRNAs that regulated more than 5 genes
as “promiscuous.” Because the predicted target gene
population for the 42 miRNAs of interest was very large,
we focused our analysis on only those gene targets that
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were regulated significantly (FDR ≤ 0.1) in our earlier rat
alveolar epithelial cell stretch study [18], where we
reported 3681 genes that are differentially expressed after
6 hours of cyclic stretch at 25% ΔSA, compared with
unstretched controls (FDR ≤ 0.1). Limiting our analysis to
miRNA gene targets that were among those 3681 genes,
and which were anti-correlated with the miRNAs in this
study (i.e., up-regulated miRNAs were targeted to down-
regulated mRNAs predicted by both MicroCosm and Tar-
getScan ≥50th context percentile), we distilled our set
down to 463 gene targets of greatest interest. These 463
genes were subjected to enrichment analysis using the
Database for Annotation, Visualization and Integrated Dis-
covery (DAVID) v6.7 functional annotation tool [39]. The
463 genes of interest were grouped according to their
Kyoto Encyclopedia of Genes and Genomes (KEGG) path-
ways, and were checked for overrepresentation relative to
a background gene list comprising the 3681 genes differen-
tially expressed with stretch. An Expression Analysis Sys-
tematic Explorer (EASE) score from a modified Fisher
exact test was calculated for each KEGG grouping, with an
EASE score of <0.05 considered significant.
Real-time PCR assay
To validate our miRNA microarray findings, we performed
real-time PCR on 6 miRNAs of interest. Using the meth-
ods described above, miRNAs were obtained from rat al-
veolar epithelial cell isolations maintained in culture for
5 days, and were either stretched at 25% ΔSA for 6 hours
(25*6) or designated as unstretched controls. Five of these
six miRNAs (miR-423-5p, miR-466d-5p, miR-378, miR-32*
and miR-15b) were validated via first-strand cDNA synthe-
sis in 20-μl reactions with sequence-specific Taqman
miRNA primers (Taqman MicroRNA reverse transcription
kit) used according to the manufacturer’s protocol. For the
sixth miRNA (miR-466f-3p), we used an NCode SYBR
Green miRNA qRT-PCR Kit (Invitrogen MIRQ-100). Real-
time PCR was performed (Taqman universal master mix
or Applied Biosystems power SYBR green PCR master
mix). Rat 4.5 s RNA was evaluated and used as an en-
dogenous control for the miRNAs.
MiRNA inhibition and permeability assay
To validate the functional significance of identified miR-
NAs, we chose two representative miRNAs up-regulated
with stretch (miR-466d-5p and miR-466f-3p). For each
of these two miRNAs, we transfected RAECs with cus-
tom-designed commercially available inhibitors prior to
stretch, and assayed the monolayer permeability. Specif-
ically, using the above-described methods, we isolated
RAECs and kept them in culture for 3 days in antibiotic-
free MEM supplemented with 10% fetal bovine serum.
On the fourth day of culture, we transfected custom-
designed, specific inhibitors of miR-466d-5p, miR-466f-
3p, or a scrambled negative control (Exiquon). These
inhibitors use a locked nucleic acid (LNA) technology,
and were conjugated to a Texas Red dye for visual con-
firmation of transfection efficiency. RAECs were trans-
fected with miRNA inhibitors or the negative control
using Lipofectamine 2000 (Invitrogen) reagent diluted in
Opti-MEM for a final miRNA inhibitor concentration of
80 nM, per manufacturer’s protocol. Optimum transfec-
tion concentration was determined by titration of differ-
ent concentrations of inhibitors (50 to 100 nM) and an
evaluation of monolayer fluorescence after 24 hours,
using >90% cellular fluorescence as a threshold for effi-
cient transfection. On the fifth day of the culture, RAECs
were serum-deprived with 20 mM Hepes supplemented
with DMEM for 2 hours, subjected to biaxial cyclic
stretch (25% ΔSA) at 37°C for 6 hours at a frequency of
0.25 Hz (15 cycles/min), or served as unstretched con-
trols, with N = 4 animals/group.
To assay for RAEC permeability, we used a small un-
charged molecule ouabain, with high affinity for the
basolateral Na+/K+-ATPase, conjugated to a nonpolar
fluorophore BODIPY, as a tracer. Our group has vali-
dated this method before [8], and demonstrated that
BODIPY-ouabain binding represents loss of tight junc-
tion integrity and increased paracellular permeability,
and that increased fluorescent signal is not a result of
cell death or intracellular uptake or transport. After 5 of
the 6 hours of equibiaxial stretch (or no stretch for con-
trols), BODIPY-ouabain (Invitrogen) diluted in dimethyl
sulfoxide was added to all cells at a final concentration
of 2 μM, and incubated for the final 1 hour of stretch. At
the end of the hour, all cells were washed with DMEM
to remove excess BODIPY-ouabain from the apical sur-
face, and were visualized under a fluorescent microscope
using a green emission filter. Presence of fluorescence
was evidence of high affinity ouabain binding to the
basolateral surface, and was used as a measure of para-
cellular permeability. Fluorescence was measured on 4
separate fields per well, and 3 wells were measured per
treatment group per animal. All measurements were
normalized to values from unstretched, untransfected
cells.
Results
In a pairwise manner, the two stretch duration groups
(25*1 and 25*6) were compared to unstretched controls.
At FDR ≤ 0.1 and a minimum of 1.5-fold increase or de-
crease, 1 miRNA was differentially expressed at 1 hour
of stretch, and 42 miRNAs were differentially expressed
at 6 hours of stretch. The single miRNA significantly up-
regulated at 1 hour (miR-423-5p) remained up-regulated
at 6 hours; another 33 miRNAs were significantly up-
regulated and another 8 miRNAs were significantly
down-regulated at 6 hours.
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The 5 miRNAs with the greatest fold-change in up- or
down-regulation at 6 hours of stretch are presented in
Table 1. The highest fold-change was a 2.9-fold increase in
miR-32*. The miRNA* designates the complementary
“passenger” transcript on the hairpin arm of the precursor
miRNA opposite the mature miRNA, and after cleavage
these usually exist at a lower frequency than the mature
miRNA [19]. Their biological relevance remains unclear.
In our array, miR-32* is significantly up-regulated with
stretch, while miR-32 is not significantly differentially
expressed, suggesting the possibility that miR-32* may be
the primary transcript or may have important functional
significance.
The functional significance of differential miRNA ex-
pression in cyclic stretch was determined using two pub-
licly available databases. TargetScan 5.1, which predicts
biological targets of mammalian miRNAs using seed-site
complementarity and 3′UTR site conservation, ranks pu-
tative targets with a context score and percentile. In-
creasing context percentiles further restricts the number
of potential target genes. TargetScan ignores most
miRNA* sequences. MicroCosm Targets (formerly miR-
Base Targets) uses the miRanda algorithm to identify po-
tential targets, and requires strict complementarity at the
seed region as well as 3′UTR site conservation. Potential
target genes must be predicted by both algorithms. In
order to further refine our list of potential miRNA tar-
gets, we restricted our gene list to mRNA demonstrated
to be differentially expressed (3681 genes at FDR ≤ 0.1)
at 25% ΔSA at 6 hours in a previous mRNA expression
analysis under identical conditions [18], and anti-
correlated with the direction of miRNA expression.
Mechanistically, miRNAs inhibit mRNA translation, but
also are often associated with a down-regulation of their
mRNA targets [40,41]; therefore, we felt that focusing on
inversely related miRNA:mRNA pairings was justified.
Using these criteria provided a list of 362 high probabil-
ity down-regulated gene targets of up-regulated miRNAs,
and 101 up-regulated targets of down-regulated miR-
NAs. Functional annotation of these 463 genes using the
DAVID tool showed multiple pathways from KEGG were
significantly overrepresented (Enrichment Analysis Sys-
tematic Explorer, EASE, score< 0.05) relative to a back-
ground of all 3681 genes significantly expressed with
cyclic stretch (Figure 1, Table 2). Several groups are at-
tractive candidates for pathways involved with cyclic
stretch, such as the vascular endothelial growth factor
(VEGF) and transforming growth factor-β (TGF-β) sig-
naling pathways, and glutathione metabolism. Interest-
ingly, all overrepresented pathways are comprised of
genes targeted by up-regulated miRNAs.
Several miRNAs targeted multiple mRNAs associated
with cyclic stretch, which we defined as “promiscuous”
miRNAs (Figure 2). Of special interest are three of the
listed up-regulated miRNAs (miR-466d-3p, miR-466d-5p,
and miR-466f-3p), which are highly expressed (> 2-fold)
as well as promiscuous, with over 25 predicted mRNA
targets each. Conversely, certain genes were predicted to
be potential targets of several miRNAs, suggesting that
the effect of miRNAs on the expression levels of these
mRNAs may be “redundant” (Figure 3).
Four of the miRNAs with large fold-changes (2 up-
and 2 down-regulated) were validated using quantitative
real-time PCR. In addition, we validated miR-423-5p,
which was the only miRNA up-regulated ≥ 1.5-fold at
both 1 and 6 hours of cyclic stretch. We also validated
miR-446f-3p, which was up-regulated 2.4-fold after 6
hours of stretch and was the most promiscuous, with
multiple predicted targets in known pathways implicated
in VILI and alveolar stretch [42]. At both 1 hour and 6
hours of stretch at 25% ΔSA, the PCR results were quali-
tatively consistent in magnitude and direction with the
expression array (Figure 4).
In order to test the functional significance of our
miRNA expression array, 2 miRNAs were chosen to
be knocked down using commercially available specific
inhibitors. We chose miR-466d-5p and miR-466f-3p
because of their relative high expression (> 2-fold)
and their promiscuity (> 25 predicted target mRNAs
each). Specific inhibition of these 2 miRNAs was asso-
ciated with a reduction in the cyclic-stretch–induced
increase in permeability back to baseline unstretched
levels, as measured by a reduction in the amount of
basolateral binding of the BODIPY-ouabain tracer
(Figure 5).
Table 1 Five largest up- and down-regulated miRNAs
miRNA probe Fold change Probable genesa predicted
by both algorithms
miR-32*b 2.9 —
miR-466c-5p 2.8 22
miR-466d-5p 2.8 30
miR-466c 2.6 4
miR-466b 2.6 7
miR-466f-3pc 2.4 38
miR-375 −1.7 13
miR-378 −1.6 18
miR-347 −1.6 23
miR-15b −1.6 21
miR-154 −1.5 16
a Probable gene targets are candidates from a parallel mRNA expression array
differentially expressed with cyclic stretch of 25% ΔSA at 6 hours, and
predicted by both MicroCosm and TargetScan algorithms; see text for details.
b The majority of miRNAs with the “*” designation are considered passenger
transcripts of a precursor miRNA, and do not have calculated TargetScan
targets.
c MiR-466f-3p is the 7th highest up-regulated miRNA, and was chosen for
subsequent validation studies; it is included here for reference.
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Discussion
Primary alveolar epithelia with type I characteristics dis-
play a duration-dependent miRNA expression profile in
response to cyclic stretch, with a single significantly up-
regulated miRNA with ≥ 1.5-fold change at 1 hour of
stretch, but 34 up- and 8 down-regulated at 6 hours, com-
pared with unstretched. These results are consistent with
our previous demonstration of increased mRNA expres-
sion differences after 6 hours of stretch relative to 1 hour
[18], suggesting an enhanced genomic response after sus-
tained cyclic stretch involving both mRNA and miRNA ex-
pression. Six of the most informative miRNAs were
validated by real-time reverse transcription PCR.
The highest fold-change in our array occurred in miR-
32*, designated a passenger transcript, and therefore not
a candidate for analysis with TargetScan 5.1. Passenger
transcripts are typically degraded, and generally exist at
significantly lower concentrations than their corre-
sponding mature miRNAs [19]. However, several recent
reports have suggested a role for miRNA* transcripts at
critical junctures in several biological processes, ranging
from miRNA and 3′UTR evolution [43] to apoptosis in
malignant cells [44,45]. Therefore, despite their lower
concentrations, miRNA* may perform important bio-
logical functions. In our array, miR-32* is 2.9-fold up-
regulated with stretch, while miR-32 is not significantly
Table 2 DAVID functional annotation
KEGGa term EASEb score Gene symbols
T cell receptor signaling pathway 0.002 ITK, PTPRC, PLCG1, CD8A, MAPK14, PIK3CD, SOS2, MAPK3, LCK, NFAT5, NFATC4, LCP2
Natural killer cell mediated cytotoxicity 0.003 CD48, PLCG1, PIK3CD, SOS2, MAPK3, LCK, NFAT5, NFATC4, SHC1, LCP2, NCR3
Purine metabolism 0.05 POLD3, POLE4, GDA, PDE6D, POLR3H, POLE2, ENPP1, NT5M, PDE8A, POLR2C, NME7
VEGF signaling pathway 0.004 SH2D2A, PLCG1, CASP9, MAPK14, PIK3CD, MAPK3, NFAT5, PLA2G2A, NFATC4
Fc epsilon RI signaling pathway 0.02 PLCG1, MAP2K3, MAPK14, PIK3CD, SOS2, MAPK3, PLA2G2A, LCP2
TGF-β signaling pathway 0.03 BMP4, INHBB, BMP2, RBL2, E2F5, ID2, TGFBR1, MAPK3
Pyrimidine metabolism 0.04 POLD3, POLE4, POLR3H, POLE2, NT5M, POLR2C, NME7, TK2
DNA replication 0.001 POLD3, POLE4, POLE2, PCNA, RNASEH1, RNASEH2A, MCM5
Nucleotide excision repair 0.004 POLD3, XPA, POLE4, POLE2, PCNA, CETN2, GTF2H2
Glutathione metabolism 0.03 GPX2, GSR, GPX3, GSTT2, ANPEP, MGST1
Non-small cell lung cancer 0.04 PDPK1, PLCG1, CASP9, PIK3CD, SOS2, MAPK3
Basal transcription factors 0.03 TAF2, GTF2E1, GTF2E2, TAF13, GTF2H2
Nicotinate and nicotinamide metabolism 0.05 NNT, ENPP1, NT5M, BST1
a Kyoto Encyclopedia of Genes and Genomes.
b Expression Analysis Systematic Explorer, a modified Fisher exact test.
Figure 1 DAVID functional annotation. The 362 predicted gene targets of up-regulated miRNAs, and the 101 predicted gene targets of down-
regulated miRNAs are grouped according to KEGG pathways with an enrichment EASE score< 0.05 relative to background gene list comprising
all 3681 genes significantly differentially expressed with cyclic stretch.
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differentially expressed, suggesting the possibility that
miR-32* may, in fact, be the primary transcript. Direct
scanning of the genome for matching 3′UTRs may re-
veal interesting candidate gene targets for miR-32*.
The predicted gene list was limited to mRNA predicted
by both MicroCosm and TargetScan with a context per-
centile ≥ 50%, and further refined to those genes with sig-
nificant differential expression with stretch in a concurrent
mRNA microarray [18] and anti-correlated with the direc-
tion of miRNA expression. Using this approach, we identi-
fied genes predicted to be high-likelihood targets of
miRNAs: 362 for up-regulated miRNAs, and 101 for
down-regulated miRNAs. Functional annotation of likely
gene targets for these miRNAs suggests a role for several
signaling pathways to be modulated by miRNAs in re-
sponse to stress and deformation. Restricting our analysis
to genes differentially expressed in a parallel mRNA ex-
pression may allow for better prediction of meaningful
targets of significant miRNAs. We further classified these
miRNA:mRNA interactions for their promiscuity (multiple
predicted gene targets) and redundancy (multiple miRNAs
with a shared target gene). While some human miRNAs
are known to have multiple predicted targets, most are
predicted to control only a few genes [46]. This classifica-
tion of our miRNAs allows us to generate hypotheses fo-
cusing on highly promiscuous miRNAs with multiple gene
targets.
Functional annotation of gene targets showed overre-
presentation of multiple pathways potentially significant
in cyclic stretch. Previous work [47] has demonstrated
that low-magnitude cyclic and sustained large-magnitude
stretch can rapidly induce expression of extracellular sig-
nal-related kinase (ERK1/2-MAPK). The up-regulated
miRNAs in our array are associated with an overrepre-
sentation of gene targets in the VEGF signaling pathway
Figure 3 “Redundant” genes with multiple miRNA target sites
within their 3’ UTR. The 362 high probability genes associated with
the 34 up-regulated miRNAs (top) and the 101 genes associated
with the 8 down-regulated miRNAs (bottom) are graphed according
to the number of predicted miRNA:mRNA matches. While most
genes are predicted to have been targeted by only a single miRNA,
the genes associated with the up-regulated miRNAs show more
redundancy, with 27 genes demonstrating ≥ 3 predicted miRNA:
mRNA matches.
Figure 2 “Promiscuous” miRNAs with multiple predicted mRNA
targets. The 34 up-regulated (top) and 8 down-regulated (bottom)
miRNAs were matched with predicted high probability mRNA
targets from a parallel mRNA expression array using TargetScan and
MicroCosm. Most miRNAs had multiple predicted gene targets. Of
the 34 up-regulated miRNAs, 8 had >25 predicted targets each; of
the 8 down-regulated miRNAs, only 3 had >20 predicted targets.
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upstream of MAPK, suggesting a possible role for miR-
NAs in regulating this response to stretch. Other overre-
presented pathways, such as glutathione metabolism,
have also been implicated in the alveolar response to
stretch [48], suggesting a role for miRNAs in regulating
oxidant release with stretch. Interestingly, the enriched
pathways were populated by gene targets associated
with only the miRNAs up-regulated with stretch, sug-
gesting that the up-regulated miRNAs may contribute
more to pathway modulation than down-regulated
miRNAs. This is supported by the higher fold-changes
for the up-regulated miRNAs.
Finally, we attempted to link the expression of the
miRNAs during cyclic stretch with a phenotype known
to be induced by stretch. Subjecting RAECs to cyclic
stretch causes a loss of tight junction integrity and leads
to increased paracellular permeability. Specific inhibition
of miR-466d-5p and miR-466f-3p resulted in a preserva-
tion of barrier permeability close to baseline unstretched
conditions, suggesting a role for these miRNAs in
Figure 4 Quantitative real-time PCR validation of miRNAs. To validate differential expression of the miRNAs, 4 of the miRNAs with the largest
fold-changes (2 up- and 2 down-regulated; see Table 1), were validated using quantitative real-time PCR with either Taqman or SYBR Green. In
addition, we performed qRT-PCR on miR-423-5p, which was the only miRNA differentially expressed at both 1 and 6 hours, and miR-466f-3p,
which was chosen for subsequent investigations. If significant (FDR of 10%), miRNA fold-change on the array is given below the corresponding
stretch duration. PCR results are qualitatively consistent in direction and magnitude with the array. N = 4-6/group. ANOVA and post-hoc Tukey
results: *p< 0.05; **p< 0.01, relative to unstretched. Expression was normalized to 4.5 s RNA.
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regulating the RAEC response to cyclic stretch. Future
investigations will address the mechanism behind this
reduced permeability. Of note, cyclic stretch leading to
an increase in reactive oxygen species [48] and a
reorganization of the cytoskeleton [49] with loss of tight
junction integrity [10,50,51] has been separately impli-
cated in leading to increased epithelial permeability. Our
study allows the investigation of specific miRNA:mRNA
interactions based on anti-correlated expression, and
allows us to focus on known oxidative stress and cyto-
skeletal pathway mRNAs as attractive potential inter-
mediaries between miRNAs and phenotypes.
Our study has several strengths. It represents the first
systematic investigation of the role of miRNAs in the med-
ically relevant process of cyclic stretch in alveolar epithelial
cells, has demonstrated a link between miRNA expression
and a phenotype (increased monolayer permeability), and
has identified pathways for further investigation. By
restricting our analyses to genes known to be differentially
expressed with cyclic stretch from a parallel mRNA micro-
array experiment, we believe we have increased the likeli-
hood of detecting relevant miRNA:mRNA interactions.
Also, the organization of miRNAs and their targets as
“promiscuous” or “redundant” allowed for more flexible
investigation of the data, and allowed us to focus on miR-
NAs with potentially higher impact targets, or those with
multiple targets. One of the theoretical advantages of
knowing miRNA differential expression is the ability to
potentially investigate the regulation of multiple genes
simultaneously. The fact that the inhibition of two of the
identified up-regulated miRNAs resulted in a dramatic
amelioration of the increased permeability seen with cyclic
stretch suggests regulation of multiple genes, or gene path-
ways, rather than control of a single locus.
Our study is limited by the fact that many of our pre-
dicted miRNA:mRNA interactions remain in silico only,
and require a separate proof of regulation on an individ-
ual basis for any given interaction. However, this is
somewhat mitigated by the use of two separate predic-
tion algorithms to identify potential targets, as well as fo-
cusing on genes known to be expressed in stretched
alveolar cells. We are also somewhat limited by the rela-
tively low expression levels of the miRNAs in stretched
cells relative to unstretched (<3-fold), making it difficult
to link robust miRNA expression or inhibition with a
phenotype. We are encouraged, however, by the clear ef-
fect on permeability seen after the specific inhibition of
miR-466d-5p and miR-466f-3p. Overall, our data set pro-
vides a starting point for investigating high-value miR-
NAs predicted to regulate multiple target genes of
interest.
Conclusions
In summary, we have investigated and described the gen-
ome-wide differential expression of miRNAs between
stretched and unstretched alveolar epithelial cells. We
have further categorized these miRNAs by their number
and types of predicted mRNA targets, and their func-
tional annotations, providing a foundation for future
investigations on the role of miRNAs in regulating the
RAEC response to cyclic stretch. Finally, we have
demonstrated a link between two miRNAs and the effect
of their inhibition on stretch-induced epithelial perme-
ability, providing one more mechanistic level of control
for this pathogenic phenotype.
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